Prescription drug abuse has become an increasingly serious problem in the United States. The introduction of Zohydro, a powerful new prescription opioid painkiller, has raised concerns about the potential for increased abuse of this drug. This article will discuss the dangers of Zohydro, the potential for abuse, and the steps that doctors can take to help prevent prescription drug abuse.
Zohydro is a prescription opioid painkiller that was approved by the Food and Drug Administration (FDA) in 2013. It is a highly potent drug, containing up to 10 times the amount of hydrocodone found in other opioid painkillers. Zohydro is intended to be used for the treatment of severe pain, such as that experienced by cancer patients or those recovering from major surgery. It is available in both extended-release and immediate-release forms, and is taken orally.
Zohydro is a powerful drug, and its potential for abuse is high. The drug has a high risk of physical and psychological dependence, and can cause serious side effects such as drowsiness, nausea, and constipation. Overdose can lead to respiratory depression, coma, and even death. In addition, the drug has no abuse-deterrent properties, meaning that it can easily be crushed and snorted or injected, making it particularly dangerous.
The potential for abuse of Zohydro is further compounded by its availability. The drug is available in both extended-release and immediate-release forms, and can be prescribed in high doses. This makes it easier for patients to obtain large quantities of the drug, and increases the risk of abuse and overdose.
Prescription drug abuse is a growing problem in the United States. According to the Centers for Disease Control and Prevention (CDC), more than 40 people die from prescription opioid overdoses each day. The introduction of Zohydro has raised concerns about the potential for increased abuse of this drug, and the potential for more overdose deaths.
In addition to the risk of physical harm, prescription drug abuse can also lead to psychological and social problems. Abusers may become isolated from family and friends, and may experience depression, anxiety, and other mental health issues. In addition, prescription drug abuse can lead to financial problems, as abusers may spend large amounts of money on the drugs.
Doctors play an important role in preventing prescription drug abuse. When prescribing Zohydro, doctors should be aware of the potential for abuse and take steps to reduce the risk. Doctors should assess patients for risk factors such as a history of substance abuse, and should monitor patients closely for signs of abuse or misuse.
Doctors should also educate patients about the dangers of prescription drug abuse. Patients should be informed of the potential for addiction, overdose, and other risks associated with the drug. In addition, doctors should provide resources to patients, such as support groups and addiction treatment centers, in case they need help.
Zohydro is a powerful prescription opioid painkiller that has the potential for abuse and addiction. Doctors should be aware of the dangers of this drug and take steps to prevent prescription drug abuse. By assessing patients for risk factors, monitoring patients closely, and educating patients about the risks associated with the drug, doctors can help to reduce the risk of abuse and overdose.
1.
Certain surgical gestures during prostate removal linked to better sexual function recovery
2.
AI tool accurately detects tumor location on breast MRI
3.
Prostate cancer early detection system eliminates need for biopsy.
4.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
5.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
1.
Decoding the Future: Cancer Genomics and Radiomics in Oncology
2.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
3.
Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology
4.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
5.
A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation